Compound 1222
Identifiers
- Canonical SMILES:
CNC(=O)Cc1ccc(Cl)cc1-n1c(nc(-c2nnc(N)o2)c1-c1ccc(F)c(Cl)c1)C1CCCCC1
- InChi:
InChI=1S/C26H25Cl2FN6O2/c1-31-21(36)12-15-7-9-17(27)13-20(15)35-23(16-8-10-19(29)18(28)11-16)22(25-33-34-26(30)37-25)32-24(35)14-5-3-2-4-6-14/h7-11,13-14H,2-6,12H2,1H3,(H2,30,34)(H,31,36)
- InChiKey:
BPVCCKVYGYMZKE-UHFFFAOYSA-N
External links
![]() 67032070 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 8.52 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 542.14 g/mol | |||
HBA | 8 | |||
HBD | 3 | |||
HBA + HBD | 11 | |||
AlogP | 4.34 | |||
TPSA | 111.86 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011023677 | 482 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 8.52 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4482 | Azeliragon | DB12689 | |
0.4167 | LY-2584702 | DB12690 | |
0.4164 | Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB02388 | |
0.4149 | Velpatasvir | DB11613 | |
0.4096 | Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB03084 | |
0.4000 | Selonsertib | DB14916 | |
0.3937 | Ralimetinib | DB11787 | |
0.3935 | Losartan | DB00678 | |
0.3932 | 4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine | DB01761 | |
0.3927 | Atorvastatin | DB01076 | |
0.3922 | Olmesartan | DB00275 | |
0.3897 | N-6022 | DB12206 | |
0.3844 | Otenabant | DB11745 | |
0.3746 | BMS-986142 | DB15291 | |
0.3737 | Cimicoxib | DB05095 |